spot-25 questionnaire
Otherspot-25 questionnaire
NCT Number: NCT04908839
Inclusion (J0):
* Audiometry (as part of the treatment, only for cases) * Clinical evaluation (within the framework of care, only for cases) * Passage of the French version of the SPOT-25 questionnaire
Visit 1 (D0 + 3 ± 1 week): only for cases Second examination of the French version of the SPOT-25 questionnaire (re-test) either by telephone and e-mail, or during a consultation or hospitalization, if this occurs within a compatible time frame.
Visit 2 (3-6 months postoperatively): only for operated patients Third examination of the French version of the SPOT-25 questionnaire either by telephone and e-mail, or during a consultation or hospitalization, if this occurs within a compatible time frame.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Amélie YAvchitz, Paris, Île-de-France Region, France
Inclusion (J0):
Visit 1 (D0 + 3 ± 1 week): only for cases Second examination of the French version of the SPOT-25 questionnaire (re-test) either by telephone and e-mail, or during a consultation or hospitalization, if this occurs within a compatible time frame.
Visit 2 (3-6 months postoperatively): only for operated patients Third examination of the French version of the SPOT-25 questionnaire either by telephone and e-mail, or during a consultation or hospitalization, if this occurs within a compatible time frame.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Inclusion criteria
for witnesses:
Exclusion criteria
spot-25 questionnaire
Time frame: 1 DAY
The SPOT-25 questionnaire includes 25 items and can be divided into 4 subscores: hearing function (items 1-10), tinnitus (items 11-13), mental condition (items 14-19), and social restrictions (items 20-24). In addition, 1 item focuses on the general evaluation of the impact of otosclerosis on HRQOL (item 25). Each question needs to be rated on a six-point ordinal scale from 0 (i.e., no impact) to 5 (i.e., most severe impact), depending on the level of inconvenience or frequency of symptoms.
Fondation Ophtalmologique Adolphe de Rothschild
Network
Acronym: QOLOTOSC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06221007
Ear Diseases, Otorhinolaryngologic Diseases
Denizli, Turkey (Türkiye)
View Trial DetailsNCT02456272
Ear Diseases, Otorhinolaryngologic Diseases
Toulouse, France
View Trial DetailsNCT06283836
Ear Diseases, Otorhinolaryngologic Diseases
Cluj-Napoca, Cluj, Romania
View Trial DetailsNCT06618053
Ear Diseases, Otorhinolaryngologic Diseases
Besançon, France
View Trial Details